Yongping Zhou

966 total citations
38 papers, 628 citations indexed

About

Yongping Zhou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yongping Zhou has authored 38 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Yongping Zhou's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Yongping Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Yongping Zhou collaborates with scholars based in China, Taiwan and United Kingdom. Yongping Zhou's co-authors include Sijin Cheng, Zhiyuan Hua, Wenzhou Ding, Wei Qian, Junsheng Fan, Yongzhao Zhao, Haixin Qian, Ting Shan, Zhihua Lu and Fang‐Ming Chen and has published in prestigious journals such as Acta Biomaterialia, Nutrients and Journal of Cellular Physiology.

In The Last Decade

Yongping Zhou

31 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongping Zhou China 15 257 218 205 113 66 38 628
Binbin Du China 18 370 1.4× 204 0.9× 199 1.0× 203 1.8× 81 1.2× 49 898
Junjiang Wang China 14 284 1.1× 165 0.8× 201 1.0× 144 1.3× 72 1.1× 69 702
Gang Zhou China 17 280 1.1× 110 0.5× 149 0.7× 119 1.1× 51 0.8× 53 645
Zhe Su China 16 307 1.2× 343 1.6× 314 1.5× 150 1.3× 66 1.0× 42 857
Gustaw Lech Poland 12 238 0.9× 181 0.8× 218 1.1× 118 1.0× 54 0.8× 37 612
Naokazu Chiba Japan 14 342 1.3× 136 0.6× 247 1.2× 182 1.6× 74 1.1× 70 770
Krista L. Denning United States 13 211 0.8× 111 0.5× 230 1.1× 108 1.0× 49 0.7× 50 585
Shiyu Du China 11 334 1.3× 175 0.8× 200 1.0× 167 1.5× 87 1.3× 33 838
Daichi Ishikawa Japan 20 340 1.3× 189 0.9× 289 1.4× 207 1.8× 109 1.7× 48 851
Dumnoensun Pruksakorn Thailand 18 370 1.4× 194 0.9× 167 0.8× 158 1.4× 81 1.2× 84 944

Countries citing papers authored by Yongping Zhou

Since Specialization
Citations

This map shows the geographic impact of Yongping Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongping Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongping Zhou more than expected).

Fields of papers citing papers by Yongping Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongping Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongping Zhou. The network helps show where Yongping Zhou may publish in the future.

Co-authorship network of co-authors of Yongping Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yongping Zhou. A scholar is included among the top collaborators of Yongping Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongping Zhou. Yongping Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fu, Tong, Yuqing Chen, Hao Wang, et al.. (2025). Bibliometric analysis of global research trends in pancreatic cancer immunotherapy. Human Vaccines & Immunotherapeutics. 21(1). 2538330–2538330.
3.
Meng, Xiangpan, Yixuan Guo, Linjie Bian, et al.. (2025). Validation of proposed imaging criteria for estimating vessels encapsulating tumor clusters in hepatocellular carcinoma at CT and gadoxetic acid-enhanced MRI. European Journal of Radiology. 183. 111936–111936.
4.
5.
Xu, Bin, Yanzhi Feng, Litao Liang, et al.. (2024). BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance. Cancer Gene Therapy. 31(12). 1868–1883.
6.
Feng, Yanzhi, Litao Liang, Bin Xu, et al.. (2024). Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis. Journal of Hepatocellular Carcinoma. Volume 11. 1095–1112. 4 indexed citations
7.
Xu, Bin, Yanzhi Feng, Litao Liang, et al.. (2024). HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA. International Journal of Biological Sciences. 20(13). 5087–5108. 3 indexed citations
8.
Meng, Xiangpan, Tianyu Tang, Yongping Zhou, et al.. (2023). Predicting post-resection recurrence by integrating imaging-based surrogates of distinct vascular patterns of hepatocellular carcinoma. JHEP Reports. 5(9). 100806–100806. 12 indexed citations
9.
Xu, Fusheng, Ruimin Chen, Chengcheng Zhang, et al.. (2023). Cholecystectomy Significantly Alters Gut Microbiota Homeostasis and Metabolic Profiles: A Cross-Sectional Study. Nutrients. 15(20). 4399–4399. 11 indexed citations
10.
Xu, Bin, Wenbo Jia, Yanzhi Feng, et al.. (2023). Exosome-transported circHDAC1_004 Promotes Proliferation, Migration, and Angiogenesis of Hepatocellular Carcinoma by the miR-361-3p/NACC1 Axis. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 5 indexed citations
11.
Liu, Jinkun, et al.. (2023). Vibration suppression and boundary control for nonlinear flexible rotating manipulator in three-dimensional space subject to output restrictions. Communications in Nonlinear Science and Numerical Simulation. 120. 107151–107151. 8 indexed citations
12.
13.
Wang, Hao, Xuhui Ge, Ning Wang, et al.. (2020). <p>Glycyrrhizic Acid Inhibits Proliferation of Gastric Cancer Cells by Inducing Cell Cycle Arrest and Apoptosis</p>. Cancer Management and Research. Volume 12. 2853–2861. 56 indexed citations
14.
Zhou, Yongping, Zhiyuan Hua, Jian Xu, et al.. (2020). LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1. Biomedicine & Pharmacotherapy. 133. 111030–111030. 27 indexed citations
15.
Chen, Fang‐Ming, et al.. (2020). Radiomics-Assisted Presurgical Prediction for Surgical Portal Vein-Superior Mesenteric Vein Invasion in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 10. 523543–523543. 9 indexed citations
16.
Chen, Qing, Qinhua Li, Yongping Zhou, et al.. (2018). The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a. Cell Cycle. 17(16). 1949–1966. 32 indexed citations
17.
Zhou, Yongping, et al.. (2018). Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies. OncoTargets and Therapy. Volume 11. 1899–1908. 50 indexed citations
18.
Zhou, Yongping, Wei Qian, Junsheng Fan, et al.. (2018). Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients. Clinica Chimica Acta. 479. 181–189. 113 indexed citations
19.
Zhou, Yongping, et al.. (2018). The prognostic value of high LncRNA AFAP1-AS1 expression in various cancers: A systematic review and meta-analysis containing 21 studies. Clinica Chimica Acta. 481. 147–153. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026